Score breakdown
Popularity is tracked separately. Support, ads, sponsorships, and tips never affect these signals.
Why it matters
Useful for .NET teams that want a real evaluation surface for agent systems instead of relying on ad-hoc demos, especially when they need repeatable checks around tool use, retrieval quality, and model behavior.
Who should use it
Who should skip it
Pass on AgentEvalHQ/AgentEval if its scope or audience does not match what your team is building right now.
About this signal
AgentEvalHQ/AgentEval is tracked by RepoRadar as a agent eval toolkit in the Evals section. It was first seen on 2026-06-29 and last updated on 2026-06-29. The current verdict is 'worth watch' with a Gold tier and moderate setup difficulty. The standout signals for AgentEvalHQ/AgentEval are open-source/build quality (8.4) and workflow potential (8.4), while maturity (6.3) trails — that balance shapes where it fits best. This page summarizes the evidence RepoRadar has captured from captured source metadata. The score, tier, risk label, and verdict on this page are never influenced by sponsorship, ads, or tips — they reflect only the usefulness, popularity, novelty, momentum, maturity, and evidence signals described in the RepoRadar methodology.
How this item is evaluated
RepoRadar assigned AgentEvalHQ/AgentEval a composite score of 8.0 out of 10, placing it in the Gold tier. This score combines weighted sub-signals: usefulness (35%), novelty (18%), momentum (14%), maturity (10%), open-source/build quality (7%), evidence quality (6%), workflow potential (6%), and setup ease (4%). Popularity is tracked separately at 1.0 and never affects the composite score or tier. The risk label of 'none' reflects inherent user-impacting hazards, not generic novelty. Items with no risk flag may still require normal code review before production use.
Putting this into practice? Read How to vet an AI agent or MCP server before you wire it in for the checklist behind this score.
Risk explanation
The maintainers label the project preview and explicitly warn against production or safety-critical use without independent validation.